Depending on who you ask, the podcast is either the best or worst thing to happen to the internet. And no matter what side you fall on in that particular debate, you’re going to want to start your own ...
Sanofi's Sarclisa has been an also-ran in the anti-CD38 antibody class behind Johnson & Johnson and Genmab's blockbuster Darzalex, but now has a chance to steal some of the spotlight. The FDA has ...
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback